Denmark’s population in 2013 to grow at a Compound Annual Growth Rate (CAGR) of 0.5% from 2008

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark is a new market research publication announced by Reportstack. This report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Denmark. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

Denmark’s population in 2013 was approximately 5.6 million, having grown at a Compound Annual Growth Rate (CAGR) of 0.5% from 2008. Denmark has a national health insurance scheme, which ensures that all of its residents have access to treatment and health services, regardless of age, income and health. In 2013, the government spent approximately $1.5 trillion on R&D and exported approximately $1.6 trillion of pharmaceutical products. The pharmaceutical market was worth $3.9 billion in 2008 and is projected to reach $3.0 billion by 2020, declining at a CAGR of 2.2%. Although the pharmaceutical market steadily increased in local currency terms between 2008 and 2013, it decreased in US dollar terms, owing to currency devaluation. The medical device market was valued at $1.3 billion in 2008 and is projected to grow at a CAGR of 4.8% to $2.3 billion in 2020, primarily attributed to - 
- An increasingly elderly population
- Universal health coverage
- Government initiatives


The report provides information on the healthcare, regulatory, and reimbursement landscape in Denmark, and includes - 
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Takeda, Novo Nordisk, Lundbeck, Leopharma and Orifarm; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, Essilor International, Johnson & Johnson Vision Care, Roche and Medtronic
- A review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to - 
- Develop business strategies by understanding the trends shaping and driving Denmark’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Denmark’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
- Identify, understand, and capitalize on the opportunities and challenges in Denmark’s healthcare market

To access full report with TOC, please visit CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark.